117 Grants (Page 4 of 5)
2009
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5U01NS055849-02), $696,319USD, 2009
2008
Evaluation of Genetic Therapy in Fancc and Fanca Mice
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-14-0003), $417,372USD, 2008
 
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
Bagby, Grover C and Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA138237-01), $397,686USD, 09/30/2008 -- 07/31/2013
 
Indiana Medical Scientist/Engineer Training Program
Clapp, David W
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1T32GM077229-01A1), $88,162USD, 07/01/2008 -- 06/30/2013
 
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA074177-11A1), $338,107USD, 04/01/1997 -- 02/28/2013
 
NF Center: From Animal Models to Therapeutics
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-04-0002), $212,903USD, 2008
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1U01NS055849-01A2-0001), $619,877USD, 07/01/2008 -- 06/30/2012
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1U01NS055849-01A2), $619,877USD, 07/01/2008 -- 06/30/2012
2007
Evaluation of Genetic Therapy in Fancc and Fanca Mice
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-13-0003), $399,793USD, 07/01/2007 -- 06/30/2010
 
NF Center: From Animal Models to Therapeutics
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-03-0002), $217,573USD, 2007
2006
Evaluation of Genetic Therapy in Fancc and Fanca Mice
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-12-0003), $379,988USD, 07/01/2006 -- 06/30/2010
 
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-10), $310,959USD, 04/01/1997 -- 06/30/2007
 
NF Center: From Animal Models to Therapeutics
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-02-0002), $202,847USD, 2006
2005
Evaluation of Genetic Therapy in Fancc and Fanca Mice
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2P01HL053586-11A1-0003), $377,796USD, 07/01/2005 -- 06/30/2010
 
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-09), $333,781USD, 04/01/1997 -- 06/30/2007
 
NF Center: From Animal Models to Therapeutics
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1P50NS052606-01-0002), $208,895USD, 07/01/2005 -- 04/30/2010
2004
EVALUATION OF GENETIC THERAPY IN FANC MICE
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-10-0003), $299,094USD, 02/29/2004 -- 02/28/2005
 
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-08), $498,147USD, 04/01/1997 -- 06/30/2007
2003
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL063219-04), $324,407USD, 09/10/2000 -- 08/31/2004
 
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-07), $484,270USD, 04/01/1997 -- 06/30/2007
2002
CORE--MOUSE
Clapp, David W
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK049218-09), $228,564USD, 09/01/2002 -- 08/31/2003
 
EVALUATION OF GENETIC THERAPY IN FANC MICE
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-08-0003), 03/01/2002 -- 02/28/2003
 
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL063219-03), $324,144USD, 09/10/2000 -- 08/31/2004
 
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA074177-06), $331,525USD, 04/01/1997 -- 06/30/2007
2001
CORE--MOUSE
Clapp, David W
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3P30DK049218-07S1), $228,564USD, 06/01/2001 -- 08/31/2001